Tronox控股 TROX 深 滬
等待開盤 01-29 09:30:00 美东时间
6.425
-0.065
-1.00%
華盛通- 最 高6.69
- 今 開6.56
- 成交量 164.28万股
- 最 低 6.35
- 昨 收 6.49
- 總市值 10.22亿
- 52周最高 9.715
- 市盈率 靜 --
- 換手率 1.03%
- 52周最低 2.81
- 委 比 -60.00%
- 總股本 1.59亿
- 歷史最高 185.085
- 量 比 0.56
- 振 幅 5.24%
- 歷史最低 -0.63
- 每 手 1
- 風險率 1.62%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tronox Holdings plc announces upcoming earnings release and webcast conference call
Tronox Holdings plc announces upcoming earnings release and webcast conference call Tronox Holdings plc will release its fourth quarter 2025 earnings on Wednesday, February 18, 2026, after market close. The results will be available via PR Newswire and on the Tronox Holdings plc website: tronox.com
01-27 05:00
Tronox Sees Q4 2025 Revenue $730M Vs $686.188M Estimate
Sales of TiO2 and zircon exceeded expectations, with TiO2 volumes increasing 13% year-over-year or 9% sequentially, primarily due to higher volumes in India. Zircon volumes increased 27% year-over-year or 42%
01-26 21:11
Tronox Q4 prelim revenue beats; plans to close Fuzhou plant
Tronox Q4 prelim revenue beats; plans to close Fuzhou plant Overview Titanium dioxide producer's preliminary Q4 revenue rose 8% yr/yr, beating analyst expectations Adjusted EBITDA for Q4 missed analyst estimates Company to close Fuzhou plant in China, citing weak demand and rising costs Outlook Tron
01-26 21:09
Tronox Q4 revenue rises 8% to USD 730 million
Tronox Q4 revenue rises 8% to USD 730 million Tronox reported preliminary financial results for the fourth quarter (Q4) of 2025. Revenue for the period was USD 730 million, representing an 8 percent increase compared to the prior year and a 4 percent rise compared to the prior quarter. The company r
01-26 21:01
BRIEF-Tronox Q4 Revenue USD 730 Million Vs. IBES Estimate USD 684.3 Million
BRIEF-Tronox Q4 Revenue USD 730 Million Vs. IBES Estimate USD 684.3 Million Jan 26 (Reuters) - Tronox Q4 adjusted EBITDA USD 57 million vs. IBES estimate USD 73 million. Q4 net income USD -176 million
01-26 21:00
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
Truist Securities Maintains Buy on Tronox Holdings, Raises Price Target to $7
Truist Securities analyst Peter Osterland maintains Tronox Holdings (NYSE:TROX) with a Buy and raises the price target from $5 to $7.
01-21 20:15
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
UBS Maintains Neutral on Tronox Holdings, Raises Price Target to $5.25
UBS analyst Joshua Spector maintains Tronox Holdings (NYSE:TROX) with a Neutral and raises the price target from $3.8 to $5.25.
01-13 06:29
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
